Evidence map›Paper›PMID 30072038›Full record

ReviewBiomaterials2019

Emerging trends in multiscale modeling of vascular pathophysiology: Organ-on-a-chip and 3D printing.

Karli Gold, Akhilesh K Gaharwar, Abhishek Jain

Abstract readReview
In one paragraph

Review in Biomaterials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Engineering in vitro vascular microsystems.Microsystems & nanoengineering · 2025
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Contribution of the ELRs to the development of advancedFrontiers in bioengineering and biotechnology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Karli GoldDepartment of Biomedical Engineering, Texas A&M University, College Station, TX, 77843, USA.
Akhilesh K GaharwarDepartment of Biomedical Engineering, Texas A&M University, College Station, TX, 77843, USA; Department of Material Sciences, Texas A&M University, College Station, TX, 77843, USA; Center for Remote Health and Technologies and Systems, Texas A&M University, College Station, TX, 77843, USA. Electronic address: gaharwar@tamu.edu.
Abhishek JainDepartment of Biomedical Engineering, Texas A&M University, College Station, TX, 77843, USA. Electronic address: a.jain@tamu.edu.
Texas A&M University · USMaterial Sciences (United States) · US

Funding

Mineralomics: Designing mineral based therapeutics to control and direct cell functionDP2EB026265 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI GAHARWAR, AKHILESH K. · 2017 to 2021
$2.4M
Two-dimensional Nanomaterials for Cartilage RegenerationR03EB023454 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI GAHARWAR, AKHILESH K. · 2017 to 2018
$139k
NIBIB NIH HHS DP2 EB026265NIBIB NIH HHS R03 EB023454
6 · The paper itself

Abstract

Most biomedical and pharmaceutical research of the human vascular system aims to unravel the complex mechanisms that drive disease progression from molecular to organ levels. The knowledge gained can then be used to innovate diagnostic and treatment strategies which can ultimately be determined precisely for patients. Despite major advancements, current modeling strategies are often limited at identifying, quantifying, and dissecting specific cellular and molecular targets that regulate human vascular diseases. Therefore, development of multiscale modeling approaches are needed that can advance our knowledge and facilitate the design of next-generation therapeutic approaches in vascular diseases. This article critically reviews animal models, static in vitro systems, and dynamic in vitro culture systems currently used to model vascular diseases. A leading emphasis on the potential of emerging approaches, specifically organ-on-a-chip and three-dimensional (3D) printing, to recapitulate the innate human vascular physiology and anatomy is described. The applications of these approaches and future outlook in designing and screening novel therapeutics are also presented.

Indexed as

Lab-On-A-Chip DevicesModels, BiologicalPrinting, Three-DimensionalAnimalsBioengineeringBlood VesselsHumansModels, Animal3D printingOrgan-on-a-chipTissue modelingVascular disease

Identifiers

PMID30072038
PMCPMC6344330
OpenAlexW2884668903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.